Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-05-18

Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused by the Disease and by Zidovudine (AZT) Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial comparing epoetin alfa to placebo for anemia in AIDS patients with anemia caused by the disease or AZT therapy; study completed evaluating safety …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EPOETIN ALFA (EPOETIN ALFA)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Acquired Immunodeficiency Syndrome, Anemia | Phase 2 | Status: COMPLETED